Nicotine maintenance for smokers in methadone treatment: a new direction

References

• American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders. 5th ed. Arlington (VA): American Psychiatric Publishing.
   Google Scholar
• Baca CT, Yahne CE. 2009. Smoking cessation during substance abuse treatment: what you need to know. J Subst Abuse Treat. 36:205–219.
   PubMed Web of Science ®Google Scholar
• Ball JC, Ross A. 2012. The effectiveness of methadone maintenance treatment: patients, programs, services, and outcome. New York (NY): Springer-Verlag.
   Google Scholar
• Bao YP, Liu ZM, Epstein DH, Du C., Shi J, Lu L. 2009. A meta-analysis of retention in methadone maintenance by dose and dosing strategy. Am J Drug Alcohol AB. 35:28–33
   PubMed Web of Science ®Google Scholar
• Blak BT, Wilson K, Metcalfe M, Maguire A, Hards M. 2010. Evaluation of varenicline as an aid to smoking cessation in UK general practice - a THIN database study. Curr Med Res Opin. 26(4):861–870.
   PubMed Web of Science ®Google Scholar
• Blase K, Fixsen D. 2013. Core intervention components: identifying and operationalizing what makes programs work. Washington (DC): Office of the Assistant Secretary for Planning and Evaluation, Office of Human Services Policy, U.S. Department of Health and Human Services.
   Google Scholar
• Bobo JK, Davis CM. 1993. Recovering staff and smoking in chemical dependency programs in rural Nebraska. J Subst Abuse Treat. 10:221–227.
   PubMed Web of Science ®Google Scholar
• Cahill K, Stevens S, Perera R, Lancaster T. 2013. Pharmacological interventions for smoking cessation: an overview of reviews. Cochrane DB Syst Rev. (5):CD009329.
   PubMed Web of Science ®Google Scholar
• Carpenter MJ, Ford ME, Cartmell MDK, Alberg AJ. 2011. Misperceptions of nicotine replacement therapy within racially and ethnically diverse smokers. J Natl Med Assoc. 103:885.
   PubMed Web of Science ®Google Scholar
• Catz SL, Jack LM, McClure JB, Javitz HS, Deprey M, Zbikowski SM, McAfee T, Richards J, Swan GE. 2011. Adherence to varenicline in the COMPASS smoking cessation intervention trial. Nicotine Tob Res. 13:361–368.
   PubMed Web of Science ®Google Scholar
• Clarke JG, Stein MD, McGarry KA, Gogineni A. 2001a. Interest in smoking cessation among injection drug users. Am J Addiction. 10:159–166.
   PubMed Web of Science ®Google Scholar
• Clarke JG, Stein MD, McGarry KA, Gogineni A. 2001b. Interest in smoking cessation among injection drug users. Am J Addiction. 10:159–166.
   PubMed Web of Science ®Google Scholar
• Clemmey P, Brooner R, Chutuape MA, Kidorf M, Stitzer M. 1997. Smoking habits and attitudes in a methadone maintenance treatment population. Drug Alcohol Depen. 44:123–132.
   PubMed Web of Science ®Google Scholar
• Cummings KM, Hyland A, Ockene JK, Hymowitz N, Manley M. 1997. Use of the nicotine skin patch by smokers in 20 communities in the United States, 1992-1993. Tob Control. 6:S63–S70.
   PubMedGoogle Scholar
• de Dios MA, Anderson BJ, Caviness CM, Stein MD. 2014. Early quit days among methadone-maintained smokers in a smoking cessation trial. Nicotine Tob Res. 16:1463–1469.
   PubMed Web of Science ®Google Scholar
• Deci E, Ryan RM. 1985. Intrinsic motivation and self-determination in human behavior. Boston (MA): Springer.
   Google Scholar
• Dunn KE, Sigmon SC, Reimann EF, Badger GJ, Heil SH, Higgins ST. 2010. A contingency-management intervention to promote initial smoking cessation among opioid-maintained patients. Exp Clin Psychopharm. 18:37–50.
   PubMed Web of Science ®Google Scholar
• Fagerström KO, Hughes JR. 2002. Nicotine concentrations with concurrent use of cigarettes and nicotine replacement: a review. Nicotine Tob Res. 4:S73–S79.
   PubMedGoogle Scholar
• Fiore MC, Jaén CR, Baker TB, et al. 2008. Treating tobacco use and dependence: 2008 update. Clinical Practice Guideline. Rockville (MD): U.S. Department of Health and Human Services. Public Health Service.
   Google Scholar
• Fiore M, Jaen C, Baker T, et al. 2008. Treating tobacco use and dependence: 2008 update. Rockville, MD: U.S. Dept. of Health and Human Services, Public Health Service.
   Google Scholar
• Fixsen DL, Blase KA, Duda MA, Naoom SF, Van Dyke M. 2010. Implementation of evidence-based treatments for children and adolescents: research findings and their implications for the future. In: J. R. Wiez, A. E. Kazdin (Eds.), Evidence-based psychotherapies for children and adolescents. New York: Guidford Press.
   Google Scholar
• Flay BR, Biglan A, Boruch RF, Castro FG, Gottfredson D, Kellam S, Mościcki EK, Schinke S, Valentine JC, Ji P. (2005). Standards of evidence: criteria for efficacy, effectiveness and dissemination. Prev Sci, 6:151–175.
   PubMed Web of Science ®Google Scholar
• Frosch DL, Nahom D, Shoptaw, S. 2002. Optimizing smoking cessation outcomes among the methadone maintained. J Subst Abuse Treat. 23:425–430.
   PubMed Web of Science ®Google Scholar
• Gerstein D, Harwood H. 1990. A study of the evolution, effectiveness, and financing of public and private drug treatment systems (Vol. 1). Washington (DC): National Academies Press (US).
   Google Scholar
• Gill M, Baljit S, Bennett M, Dwayne L, Abu-Salha M, Fore-Arcand Ed DL. 2002. Addiction Professionals' attitudes regarding treatment of nicotine dependence. Jefferson J Psychiat. 17:5.
   Google Scholar
• Guydish J, Passalacqua E, Tajima B, Chan M, ChunJ, Bostrom A. 2011. Smoking prevalence in addiction treatment: a review. Nicotine Tob Res. 13:401–411.
   PubMed Web of Science ®Google Scholar
• Hajek P, Tonnesen P, Arteaga C., Russ C, Tonstad S. 2009. Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatment. Addiction. 104:1597–1602.
   PubMed Web of Science ®Google Scholar
• Hall KL, Rossi JS. 2008. Meta-analytic examination of the strong and weak principles across 48 health behaviors. Prev Med. 46:266–274.
   PubMed Web of Science ®Google Scholar
• Halperin AC, McAfee TA, Jack LM, Catz SL, McClure JB, Deprey TM, Richards J, Zbikowski SM, Swan GE. 2009. Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting. J Subst Abuse Treat, 36:428–434.
   PubMed Web of Science ®Google Scholar
• Haug C. 2004. Passive smoking–active debate. Tidsskr Nordke Laege. 124:307.
   PubMedGoogle Scholar
• Haug NA, Svikis DS, Diclemente C. 2004. Motivational enhancement therapy for nicotine dependence in methadone-maintained pregnant women. Psychol Addict Behav. 18:289–292.
   PubMed Web of Science ®Google Scholar
• Havassy B, Hargreaves WA, De Barros L. 1979. Self-regulation of dose in methadone maintenance with contingent privileges. Addict Behav. 4:31–38.
   PubMed Web of Science ®Google Scholar
• Hser YI, Hoffman V, Grella CE, Anglin MD. 2001. A 33-year follow-up of narcotics addicts. Arch. Gen. Psychiat. 58:503–508. [pii]
   PubMed Web of Science ®Google Scholar
• Hser YI, McCarthy WJ, Anglin MD. 1994. Tobacco use as a distal predictor of mortality among long-term narcotics addicts. Prev Med. 23:61–69. [pii]10.1006/pmed.1994.1009
   PubMed Web of Science ®Google Scholar
• Hurt RD, Offord KP, Croghan IT, Gomez-Dahl L, Kottke TE, Morse RM, Melton LJ, 3rd. 1996. Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA. 275:1097–1103.
   PubMed Web of Science ®Google Scholar
• Karki P, Shrestha R, Huedo-Medina TB, Copenhaver M. 2016. The impact of methadone maintenance treatment on HIV risk behaviors among high-risk injection drug users: a systematic review. Evid Based Med Public Health. 2:1–11.
   Google Scholar
• Knudsen HK. 2017. Implementation of smoking cessation treatment in substance use disorder treatment settings: a review. Am J Drug Alcohol AB. 43:215–225.
   PubMed Web of Science ®Google Scholar
• Knudsen HK, Studts JL, Boyd S, Roman PM. 2010. Structural and cultural barriers to the adoption of smoking cessation services in addiction treatment organizations. J. Addict Dis. 29:294–305.
   PubMed Web of Science ®Google Scholar
• Kreek MJ. 1992. Rationale for maintenance pharmacotherapy of opiate dependence. Res Publ Assoc Res N. 70:205–230.
   PubMedGoogle Scholar
• Lam TH, Abdullah AS, Chan SS, Hedley AJ, Hong Kong Council on, S, Health Smoking Cessation Health Centre Steering, G. (2005). Adherence to nicotine replacement therapy versus quitting smoking among Chinese smokers: a preliminary investigation. Psychopharmacology. 177:400–408.
   PubMed Web of Science ®Google Scholar
• Lind B, Chen S, Weatherburn D, Pie P, Mattick R. 2005. The effectiveness of methadone maintenance treatment in controlling crime: an Australian aggregate-level analysis. Brit. J. Criminol. 45:201–211.
   Web of Science ®Google Scholar
• Lippke S, Ziegelmann JP. 2008. Theory-Based health behavior change: Developing, testing, and applying theories for evidence based interventions. Applied Psychology. 57:698–716.
   Web of Science ®Google Scholar
• Mattick RP, Breen C, Kimber J, Davoli M. 2009. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane DB Syst Rev. (3):CD002209.
   PubMed Web of Science ®Google Scholar
• McNeill A, Munafò, MR. 2013 Reducing harm from tobacco use. J Psychopharmacol. 27:13–18.
   PubMed Web of Science ®Google Scholar
• Miller WR, Rollnick S. 2013. Motivational Interviewing: Helping people change. New York, NY: Guilford Press.
   Google Scholar
• Mooney ME, Poling J, Gonzalez G, Gonsai K, Kosten T, Sofuoglu M. 2008. Preliminary study of buprenorphine and bupropion for opioid-dependent smokers. Am J Addiction. 17:287–292.
   PubMed Web of Science ®Google Scholar
• Murray RP, Connett JE, Zapawa LM. 2009. Does nicotine replacement therapy cause cancer? Evidence from the Lung Health Study. Nicotine Tob. Res. 11:1076–1082.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. 2013. Tobacco: harm-reduction approaches to smoking. (NICE public health guidance 44). London (UK): NICE.
   Google Scholar
• Orzechowski B, Walker R. 2005. The tax burden on tobacco, 40. Atlanta (GA): Centers for Disease Control and Prevention. https://chronicdata.cdc.gov/d/fip8-rcng.
   Google Scholar
• Padaiga Z, Subata E, Vanagas G. 2007. Outpatient methadone maintenance treatment program. Quality of life and health of opioid-dependent persons in Lithuania. Medicina. 43:235–241.
   PubMedGoogle Scholar
• Pang L, HaoY, Mi G, Wang C, Luo W, Rou K, Li J, Wu Z. 2007. Effectiveness of first eight methadone maintenance treatment clinics in China. AIDS. 21:S103–S107.
   PubMed Web of Science ®Google Scholar
• Piper ME, Smith SS, Schlam TR, Fiore MC, Jorenby DE, Fraser D, Baker TB. 2009. A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Arch Gen Psychiat. 66:1253–1262.
   PubMed Web of Science ®Google Scholar
• Prochaska JJ. 2015. Nicotine replacement therapy as a maintenance treatment. Jama. 314:718–719.
   PubMed Web of Science ®Google Scholar
• Richter KP, Gibson CA, Ahluwalia JS, Schmelzle KH. 2001. Tobacco use and quit attempts among methadone maintenance clients. Am J Public Health. 91:296–299.
   PubMed Web of Science ®Google Scholar
• Richter KP, McCool RM, Okuyemi KS, Mayo MS, Ahluwalia JS. 2002. Patients' views on smoking cessation and tobacco harm reduction during drug treatment. Nicotine Tob Res. 4:S175–S182.
   PubMedGoogle Scholar
• Robles E, Miller FB, Gilmore-Thomas KK, McMillan DE. 2001. Implementation of a clinic policy of client-regulated methadone dosing. J Subst Abuse Treat. 20:225–230; discussion 231.
   PubMed Web of Science ®Google Scholar
• Rosen D, Smith ML, Reynolds CF, 3rd. 2008. The prevalence of mental and physical health disorders among older methadone patients. Am J Geriat Psychiat. 16:488–497.
   PubMed Web of Science ®Google Scholar
• Sanders JJ, Roose RJ, Lubrano MC, Lucan SC. 2013. Meaning and methadone: patient perceptions of methadone dose and a model to promote adherence to maintenance treatment. J Addict Med. 7:307–313.
   PubMed Web of Science ®Google Scholar
• Schroeder SA. 2005. What to do with a patient who smokes. JAMA. 294:482–487.
   PubMed Web of Science ®Google Scholar
• Sees KL, Clark HW. 1993 When to begin smoking cessation in substance abusers. J Subst Abuse Treat. 10:189–195.
   PubMed Web of Science ®Google Scholar
• Sees KL, Delucchi KL, Masson C, et al. 2000. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. JAMA. 283:1303–1310.
   PubMed Web of Science ®Google Scholar
• Shahab L, Dobbie F, Hiscock R, McNeill A, Bauld L. 2018. Prevalence and impact of long-term use of nicotine replacement therapy in UK Stop-Smoking Services: findings from the ELONS study. Nicotine Tob Res. 20:81–88.
   Web of Science ®Google Scholar
• Shiffman S, Paty JA, Gnys M, Kassel JA, Hickcox M. 1996. First lapses to smoking: within-subjects analysis of real-time reports. J Consult Clin Psych. 64:366–379.
   PubMed Web of Science ®Google Scholar
• Shiffman S, Sweeney CT, Ferguson SG, Sembower MA, Gitchell JG. 2008. Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers. Clin Ther. 30:1852–1858.
   PubMed Web of Science ®Google Scholar
• Shoptaw S, Rotheram-Fuller E, Yang X, Frosch D, Nahom D, Jarvik ME, Rawson RA, Ling W. 2002. Smoking cessation in methadone maintenance. Addiction. 97:1317–1328; discussion 1325.
   PubMed Web of Science ®Google Scholar
• Sims TH, Fiore MC. 2002. Pharmacotherapy for treating tobacco dependence. CNS drugs. 16:653–662.
   PubMed Web of Science ®Google Scholar
• Song F, Raftery J, Aveyard P, Hyde C, Barton P, Woolacott N. 2002. Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis. Med Decis Making. 22:26–37.
   Web of Science ®Google Scholar
• Stead LF, Perera R, Bullen C, Mant D, Lancaster T. 2008. Nicotine replacement therapy for smoking cessation. Cochrane DB Syst Rev. (1):CD000146.
   PubMed Web of Science ®Google Scholar
• Stein MD, Caviness CM, Kurth ME, Audet D, Olson J, Anderson BJ. 2013a. Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial. Drug Alcohol Depen.
   Web of Science ®Google Scholar
• Stein MD, Caviness CM, Kurth ME, Audet D, Olson J, Anderson BJ. 2013b. Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial. Drug Alcohol Depen. 133:486–493.
   PubMed Web of Science ®Google Scholar
• Stein MD, Weinstock MC, Herman DS, Anderson BJ. 2005. Respiratory symptom relief related to reduction in cigarette use. J Gen Intern Med. 20:889–894.
   PubMed Web of Science ®Google Scholar
• Stein MD, Weinstock MC, Herman DS, Anderson BJ, Anthony JL, Niaura, R. 2006. A smoking cessation intervention for the methadone-maintained. Addiction. 101:599–607.
   PubMed Web of Science ®Google Scholar
• Story J, StarkMJ. 1991. Treating cigarette smoking in methadone maintenance clients. J Psychoactive Drugs. 23:203–215.
   PubMed Web of Science ®Google Scholar
• Taskinen M-R, Smith U. 1996. Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance. Circulation. 94:878–881.
   PubMed Web of Science ®Google Scholar
• UNODC. 2017United Nations Office on Drugs and Crime: World Drug Report 2017.
   Google Scholar
• Ward J, Mattick RP, Hall W. 1994. The effectiveness of methadone maintenance treatment: an overview. Drug Alcohol Rev. 13:327–336.
   PubMedGoogle Scholar
• Weinrich M, StuartM. 2000. Provision of methadone treatment in primary care medical practices: review of the scottish experience and implications for us policy. JAMA. 283:1343–1348.
   PubMed Web of Science ®Google Scholar
• WHO Model List of Essential Medicines. 2015. Retrieved from http://www.who.int/selection_medicines/committees/expert/20/EML_2015_FINAL_amended_AUG2015.pdf?ua =1
   Google Scholar
• Williams G, Freedman Z, Deci E. 1998a. Supporting autonomy to motivate glucose control in patients with diabetes. Diabetes. 47:6A.
   Web of Science ®Google Scholar
• Williams GC, Grow VM, Freedman ZR, Ryan RM, Deci EL. 1996. Motivational predictors of weight loss and weight-loss maintenance. J Pers Soc Psychol. 70:115.
   PubMed Web of Science ®Google Scholar
• Williams GC, Rodin GC, Ryan RM, Grolnick WS, Deci EL. 1998b. Autonomous regulation and long-term medication adherence in adult outpatients. Health Psychol. 17:269.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2009. Department of mental health, substance abuse, world health organization, international narcotics control board, & United Nations office on drugs. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. World Health Organization.
   Google Scholar
• Yanos PT, Lucksted A, Drapalski AL, Roe D, Lysaker P. 2015. Interventions targeting mental health self-stigma: a review and comparison. Psychiatric Rehabil J. 38:171.
   PubMed Web of Science ®Google Scholar